Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

Donald Trump plans to impose new tariffs on pharmaceuticals and semiconductors to boost manufacturing in the US.

Several drugmakers, including AstraZeneca and Eli Lilly, have already pledged major investments in U.S. manufacturing.